{"product_id":"immunotherapy-of-cancers-limmunoth-rapie-des-cancers-9782738145970","title":"Immunotherapy of cancers \/ L'Immunoth rapie des cancers","description":"\u003cp\u003e • Author(s): Eric Vivier | Marc Da Ron\u003cbr\u003e • Publisher: Odile Jacob\u003cbr\u003e • Publisher Imprint: Odile Jacob\u003cbr\u003e • BISAC: Life Sciences - General\u003c\/p\u003e\u003cp\u003eEric Vivier, professor of immunology at the Universit Aix-Marseille, is honorary director of the Centre d'immunologie de Marseille-Luminy and director of research at the biotechnology company Innate-Pharma. He is also a member of the French Acad mie de m decine and the Institut Universitaire de France.Marc Da�ron, director of research at Inserm [French National Institute of Health and Medical Research], former director of the department of immunology at the Institut Pasteur, is a member of the Institut d'histoire et de philosophie des sciences et des techniques.We have known for a long time that the immune system is capable of ridding an organism of all intruders that might threaten its survival. All, or almost all: a cancerous tumor is the exception. Without our knowing why, a cancer cell thwarts immune system alerts, and calmly proliferates, whereas killer cells and other lymphocytes nearby could eliminate it in just a few hours.The idea of reprogramming the immune system to fight cancer cells through the development of antibody-producing medication, is shaping up to be a true therapeutic revolution. Today, in conjunction with classic approaches (chemotherapy and radiation), it is gradually gaining ground. Great success has already been recorded, alongside unexplained failures, which stresses the power of the approach, but also the challenges involved: it's a matter of awakening the immune system, but not of inciting it to declare war on the entire organism Here the authors tell the enthralling story of new cancer immunotherapies, from the first observations at the beginning of the twentieth century to the discovery of checkpoints that block immunity, and the development of the first generation of anti-cancer medication which frees up immunity. A notable fact: this scientific revolution is accompanied by an unprecedented reorganization of collaborations between research and industry, the guarantee of increased effectiveness. Immuno-oncology is being born under the best auspices, and it will make headlines in the years to come. \/ Malgr des progr s consid rables et d ind niables succ s th rapeutiques, le cancer reste une des premi res causes de mortalit . Issue de travaux de recherche fondamentale, la d couverte des m canismes qui contr lent les r ponses du syst me immunitaire a permis de concevoir de nouvelles approches th rapeutiques qui se sont r v l es remarquablement efficaces sur des cancers jusqu ici sans espoir. L id e consiste permettre aux d fenses naturelles, que nous poss dons tous, d agir sur le cancer.Ce livre raconte l histoire des recherches et des id es qui ont conduit cette r volution m dicale. De m me qu il y a eu un avant et un apr s la d couverte des antibiotiques, on peut d ores et d j penser qu il y aura un avant et un apr s l immunoth rapie des cancers.\u003c\/p\u003e","brand":"Odile Jacob","offers":[{"title":"Paperback","offer_id":47969080672407,"sku":"9782738145970","price":3938.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0666\/3471\/1191\/files\/9782738145970.webp?v=1782920387","url":"https:\/\/atlanticbooks.com\/products\/immunotherapy-of-cancers-limmunoth-rapie-des-cancers-9782738145970","provider":"Atlantic Books","version":"1.0","type":"link"}